Tissue Core
组织核心
基本信息
- 批准号:10333182
- 负责人:
- 金额:$ 16.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-02-18 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccreditationActive SitesAddressAffectAmericanAnimal ModelBiologicalBiological AssayBloodBlood specimenCancer CenterCancer Center Support GrantCatchment AreaCellsClinicalClinical SciencesClinical TrialsCollaborationsCollectionCommunicationConsultCustomDataDevelopmentDissociationDocumentationDysmyelopoietic SyndromesEnsureEthicsFoundationsFractionationFreezingFundingFutureGenerationsGenomicsGoalsGrantGrowthGuidelinesHealth Service AreaHistologyHumanImmunohistochemistryIn SituIn Situ HybridizationIndividualLaboratoriesLiquid substanceManuscriptsMinority GroupsMolecularMolecular AnalysisNational Heart, Lung, and Blood InstituteNatural HistoryNucleic AcidsOperative Surgical ProceduresOutcomePathologistPatientsPeer ReviewPoliciesPopulationProceduresProcessProteomicsProtocols documentationPublicationsRecommendationReproducibilityResearchResearch DesignResource SharingResourcesReview CommitteeScienceSeriesServicesSpecimenSpecimen HandlingStandardizationTargeted ResearchTestingTimeTissue BanksTissue MicroarrayTissuesTraining and EducationTranslational ResearchUnited States National Institutes of HealthUpdatebasebiobankbiological specimen archivescancer careclinical applicationcollegedesignepigenomicsexosomeimprovedlaboratory experienceliquid biopsymembermetabolomicsnovelpatient populationperipheral bloodprogramsquality assurancesample collectionstool sampletranslational studytumor
项目摘要
PROJECT SUMMARY
TISSUE CORE
The Tissue Core (TC) serves as the central biorepository for Moffitt Cancer Center (Moffitt). Opened in 1992,
the overall goal of TC is to collect, process, store, and release high-quality, well-annotated biospecimens in
support of basic, clinical, population, quantitative and translational research. TC provides a wide variety of
services including fresh frozen tissue collection, histology, immunohistochemistry, nucleic acid extraction,
generation of tissue microarrays, and archived biospecimen release. Further, TC consults on and implements
project-specific SOPs, including study design and collection strategies to optimize specimen handling. TC offers
75 distinct services that meet or exceed NCI best practice recommendations and CAP Biorepository
Accreditation standards, which ensures rigor and reproducibility in sample collection and processing that is
validated through standardization, documentation, and quality management. TC activities towards its goals are
organized into three Specific Aims:
Aim 1: To serve as the centralized Moffitt biobanking resource for the collection, processing, and storage of
biospecimens.
Aim 2: To facilitate and ensure access to high-quality biospecimens and state-of-the-science services through
implementation of biorepository best practices.
Aim 3: To enrich Member research through streamlined utilization, biospecimen education and training that
ensures high-quality outcomes.
Over the previous funding cycle, TC services continued to improve efficiency, communication, and turn-around
times and the TC addressed the evolving complexity of specimen collection to support novel projects. This
yielded three new service sections: Biospecimen Processing Services, TC Total Cancer Care Section to support
Moffitt’s institutionally funded biobanking protocol, and TC Clinical Trial Biospecimen Services, which provides
dedicated support for clinical trials. Further, TC collaborates as an active site for NIH consortium projects such
as the Clinical Proteomic Tumor Analysis Consortium that provides biospecimen collection, processing,
dissemination and data annotation via Moffitt’s Total Cancer Care institutional biobanking protocol. TC also
serves as the Central Lab and Biorepository for NHLBI’s National Myelodysplastic Syndrome Natural History
Study. Over the last five years, TC contributed to 188 publications (37 high impact) and 154 grants. In FY20
alone, TC supported 120 Members (69% peer review funded) in all five Programs (CBE 18 %, CE 18 %, MM 31
%, HOB 5%, IO 28%). Collectively, TC supported 350 protocols during FY20. Of those protocols, 219 were
clinical trials, increasing from 93 in FY2019 and 64 in FY2018.
项目总结
组织芯
组织核心(TC)是莫菲特癌症中心(Moffitt)的中心生物储存库。1992年开业,
TC的总体目标是收集、处理、存储和释放高质量的、注释良好的生物标本
支持基础研究、临床研究、人口研究、定量研究和转化研究。TC提供了广泛的
服务包括新鲜冰冻组织收集、组织学、免疫组织化学、核酸提取、
组织微阵列的生成和生物样品的归档释放。此外,TC还就以下事项进行咨询和实施
针对具体项目的标准操作规程,包括优化标本处理的研究设计和收集策略。TC优惠
符合或超过NCI最佳实践建议和CAP生物存储库的75项不同服务
认证标准,确保样本收集和处理的严密性和重复性,即
通过标准化、文档和质量管理进行验证。为实现其目标开展的技术合作活动包括
组织成三个具体目标:
目标1:作为集中的Moffitt生物库资源,收集、处理和存储
生物群落。
目标2:通过以下方式便利和确保获得高质量的生物检疫和最新科学服务
实施生物信息库最佳做法。
目标3:通过简化利用、生物科学教育和培训来丰富成员研究
确保高质量的成果。
在前一个资金周期中,TC服务继续提高效率、沟通和周转
《泰晤士报》和TC解决了标本收集的日益复杂的问题,以支持新的项目。这
产生了三个新的服务部门:生物制品加工服务、TC全面癌症护理科以支持
Moffitt的机构资助的生物库协议和TC临床试验Biospecimen服务,该服务提供
为临床试验提供专门支持。此外,TC作为NIH财团项目的积极站点进行合作
作为临床蛋白质组肿瘤分析联盟,提供生物样品收集、处理、
通过莫菲特的全面癌症护理机构生物库协议进行传播和数据注释。TC也
作为NHLBI全国骨髓增生异常综合征自然病史的中心实验室和生物库
学习。在过去五年中,技术合作委员会为188份出版物(37份高影响力)和154份赠款作出了贡献。在2020财年
仅在所有五个项目中,TC就支持了120名成员(69%由同行评审资助)(CBE 18%,CE 18%,MM 31
%,HOB 5%,IO 28%)。在2020财年期间,TC总共支持350个协议。在这些协议中,有219项是
临床试验,2019财年为93项,2018财年为。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Conor C Lynch其他文献
Conor C Lynch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Conor C Lynch', 18)}}的其他基金
Role of ULK3 in Sensitive and Refractory Multiple Myeloma
ULK3 在敏感和难治性多发性骨髓瘤中的作用
- 批准号:
10587461 - 财政年份:2022
- 资助金额:
$ 16.22万 - 项目类别:
Local and systemic control of multiple myeloma colonization and growth by MMP-13
MMP-13 对多发性骨髓瘤定植和生长的局部和全身控制
- 批准号:
10620155 - 财政年份:2019
- 资助金额:
$ 16.22万 - 项目类别:
Local and systemic control of multiple myeloma colonization and growth by MMP-13
MMP-13 对多发性骨髓瘤定植和生长的局部和全身控制
- 批准号:
10349508 - 财政年份:2019
- 资助金额:
$ 16.22万 - 项目类别:
Local and systemic control of multiple myeloma colonization and growth by MMP-13
MMP-13 对多发性骨髓瘤定植和生长的局部和全身控制
- 批准号:
10116330 - 财政年份:2019
- 资助金额:
$ 16.22万 - 项目类别:
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases
宿主MMP介导的前列腺骨转移恶性循环的调节
- 批准号:
8464659 - 财政年份:2010
- 资助金额:
$ 16.22万 - 项目类别:
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases
宿主MMP介导的前列腺骨转移恶性循环的调节
- 批准号:
8232258 - 财政年份:2010
- 资助金额:
$ 16.22万 - 项目类别:
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases
宿主MMP介导的前列腺骨转移恶性循环的调节
- 批准号:
7987479 - 财政年份:2010
- 资助金额:
$ 16.22万 - 项目类别:
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases
宿主MMP介导的前列腺骨转移恶性循环的调节
- 批准号:
8657863 - 财政年份:2010
- 资助金额:
$ 16.22万 - 项目类别:
Host MMP-mediated regulation of the vicious cycle of prostate to bone metastases
宿主MMP介导的前列腺骨转移恶性循环的调节
- 批准号:
8082805 - 财政年份:2010
- 资助金额:
$ 16.22万 - 项目类别:
相似海外基金
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 16.22万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 16.22万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 16.22万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 16.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 16.22万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 16.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 16.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 16.22万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 16.22万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 16.22万 - 项目类别:
Discovery Grants Program - Individual